These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3484646)
1. Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2. Cukrová V; Hrkal Z; Koprivová H; Neuwirt J Blut; 1986 Jan; 52(1):51-8. PubMed ID: 3484646 [TBL] [Abstract][Full Text] [Related]
2. Acidic isoferritins (leukemia-associated inhibitory activity) fail to inhibit blast proliferation in acute myelogenous leukemia. Taetle R Blood; 1981 Sep; 58(3):653-7. PubMed ID: 6973349 [TBL] [Abstract][Full Text] [Related]
3. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. Broxmeyer HE; Bognacki J; Dorner MH; de Sousa M J Exp Med; 1981 Jun; 153(6):1426-44. PubMed ID: 6972999 [TBL] [Abstract][Full Text] [Related]
4. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias. Olsson I; Olofsson T Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222 [TBL] [Abstract][Full Text] [Related]
5. Monocyte-macrophage-derived acidic isoferritins: normal feedback regulators of granulocyte-macrophage progenitor cells in vitro. Broxmeyer HE; Bognacki J; Ralph P; Dörner MH; Lu L; Castro-Malaspina H Blood; 1982 Sep; 60(3):595-607. PubMed ID: 6980676 [TBL] [Abstract][Full Text] [Related]
6. [Determination of inhibitory activity derived from leukemic cells and its use in clinical practice]. Cukrová V; Neuwirtová R; Novák F; Cermák J Vnitr Lek; 1987 Mar; 33(3):241-7. PubMed ID: 3499031 [No Abstract] [Full Text] [Related]
7. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells. Olofsson T; Sallerfors B Exp Hematol; 1987 Dec; 15(11):1163-7. PubMed ID: 3500070 [TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells. Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470 [TBL] [Abstract][Full Text] [Related]
9. Splenic granulocytopoiesis and production of colony-stimulating activity in lymphoma and leukemia. Greenberg PL; Steed SM Blood; 1981 Jan; 57(1):119-29. PubMed ID: 6969608 [TBL] [Abstract][Full Text] [Related]
10. Characterization of hemopoietic activities in media conditioned by a murine marrow-derived adherent cell line, B.Ad. Li CL; Culter RL; Johnson GR Exp Hematol; 1987 May; 15(4):373-81. PubMed ID: 3494626 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of normal erythropoiesis in mice with Friend virus induced erythroleukemia. Johnson CS; Marcelletti J; Longley C; Furmanski P Exp Hematol; 1982 Oct; 10(9):743-53. PubMed ID: 6983451 [TBL] [Abstract][Full Text] [Related]
12. Leukemia-associated inhibitory activity in acute leukemia developed from myelodysplastic syndrome. Fukuoka T; Fujita S Jpn J Med; 1987 Aug; 26(3):314-8. PubMed ID: 3501031 [TBL] [Abstract][Full Text] [Related]
13. Suppression of normal hematopoiesis in acute leukemia: effect of leukemic cells on bone marrow stromal cells and hematopoietic progenitor cells. Aoyagi M; Furusawa S; Waga K; Tsunogake S; Shishido H Intern Med; 1994 May; 33(5):288-95. PubMed ID: 7949632 [TBL] [Abstract][Full Text] [Related]
14. Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia. Broxmeyer HE; Grossbard E; Jacobsen N; Moore MA N Engl J Med; 1979 Aug; 301(7):346-51. PubMed ID: 313511 [TBL] [Abstract][Full Text] [Related]
15. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium. Taetle R; Caviles A; Koziol J Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965 [TBL] [Abstract][Full Text] [Related]
16. [Application of human placental conditioned medium on granulocyte and macrophage colony formation by human bone marrow cells (author's transl)]. Suzuki C; Mizoguchi H; Miura Y; Kubota K; Suda T; Katsunuma H; Takaku F Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):406-13. PubMed ID: 315148 [No Abstract] [Full Text] [Related]
17. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D; Strife A; Atzpodien J; Clarkson BD Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231 [TBL] [Abstract][Full Text] [Related]
18. Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus. Broxmeyer HE; Ralph P; Gilbertson S; Margolis VB Cancer Res; 1980 Nov; 40(11):3928-33. PubMed ID: 6258770 [TBL] [Abstract][Full Text] [Related]
19. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580 [TBL] [Abstract][Full Text] [Related]
20. Leukemic cell-associated inhibitory activity against CFU-C of normal bone marrow. Itoh K; Fujioka S; Yoshida S Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):47-54. PubMed ID: 3873776 [No Abstract] [Full Text] [Related] [Next] [New Search]